INTRODUCTION 52 53
Substantial evidence has shown a clear association of adverse intrauterine environment 54
with an increased incidence of cardiovascular disease and hypertension later in the life (4, 5, 14, 55 32), suggesting that the prenatal environment can change the postnatal physiology, namely 56 "programming". Programming is a result of adaptive alterations in gene expression patterns and 57 phenotype in response to the in utero stresses, which modify the growth of specific organs during 58 the critical period of development in early life (30). This may predispose the organism to a 59 heightened susceptibility of cardiovascular disease in its adult life. Multiple stimuli have been 60 identified as being capable of inducing fetal programming in animal models, including 61 malnourishment, exposure to hypoxia, cocaine, nicotine or glucocorticoid during the pregnancy 62 (2, 14, 25, 32, 37, 48, 50) . Recent animal studies have demonstrated that fetal hypoxia is linked 63 to early changes in the developing cardiovascular system (6, 37, 39). In fact, "physiological 64 hypoxia" is a normal part of fetal life for all vertebrates and it plays an active role in 65 vasculogenesis, angiogenesis, hematopoeisis and chondrogenesis during the fetal development 66 (39). The partial oxygen tension of embryo is below 10 mmHg, which is regarded as being 67 hypoxic compared with normal adult tissues with the oxygen tension of 20-40 mmHg (45), 68
indicating that the fetus is persistently hypoxic during the organ formation, growth and 69 maturation, and that fetal tissues have a lower threshold to reach a state of oxygen insufficiency 70 (38). Although a restricted oxygen supply is essential for intrauterine growth, excessive or severe 71 hypoxia may compromise the normal fetal or neonatal development. The fetus may experience 72 prolonged hypoxia under various conditions, such as pregnancy at high altitude, pregnancy with 73 smoke, drug abuse, anemia, pulmonary disease, hypertension, etc. Fetal exposure to 74 pathophysiological hypoxia results in the redistribution of blood flow to facilitate oxygen 75 delivery to the vital organs, such as the brain and heart (41). In rodents, the heart is particularly 76 vulnerable to stressors, such as hypoxia, during the late fetal development and early postnatal life 77 when it undergoes rapid growth and maturation (30). The maturation process of cardiomyocytes 78 in rats occurs over postnatal day 4 to 12, which is marked by binucleation and escape from the 79 cell cycle (51). Nonetheless, little is known about cardiac remodeling and related genes 80 expression patterns in the heart during the critical developmental stages of the fetus and neonate 81 in response to fetal hypoxia. 82
It has been demonstrated that the timely breakdown and restructure of extracellular 83 matrix (ECM) are critical for the normal fetal organ development (33). ECM is a complicated 84 microenvironment including numerous matrix proteins (such as collagens), signaling molecules, 85 proteases, and all of them contribute to the tissue remodeling process (40). The functional 86 integrity of myocardium depends largely on the extracellular collagenous matrix (31). Aberrant 87 amount, distribution or organization of fibrillar collagens in the myocardium is associated with 88 various pathophysiological changes in the heart (18). Many factors that participate in the 89 cardiac tissue remodeling have been revealed and matrix metalloproteinases (MMPs) are the one 90 of the most significant mediators in the ECM turnover. MMPs are a family of zinc-dependent 91 proteases that consist of at least 25 different MMPs in vertebrate (12). Although the most studied 92
MMPs in the heart are gelatinases, MMP-2 and MMP-9 that are capable of degrading type I and 93 IV collagens, the major types of fibrillar collagens in the heart are type I and III collagens that 94 are digested mainly by collagenase-1 (MMP-1) and collagenase-3 (MMP-13), respectively (40, 95 42, 44). In addition to the secreted MMPs, there is a unique subfamily of MMPs, namely 96 membrane type-(MT-) MMPs. MT-MMPs (MT1-MT6 MMPs) have been identified to be fully 97 active enzymes once inserted into the cell membrane, rather than being secreted in the 98 proenzyme form. Among the six types of MT-MMPs, MT1-MMP is highly expressed and is a 99 primary enzyme that digests fibrillar collagens in the heart in addition to collagenases (10, 36, 100 40). Together with the four types of tissue inhibitors of metalloproteinases (TIMPs) identified, 101
MMPs have been implicated in a variety of physiological and pathological processes in the 102 cardiovascular system, ranging from fibrillar collagen digesting in the heart formation and 103
growth to cardiac ischemia-reperfusion injury (23). Yet whether and to what extent MMPs and 104
TIMPs expression patterns in the fetal heart are altered by in utero hypoxia remain to be elusive. 105
Herein, we present evidence in a rat model that maternal hypoxia during gestation alters MMPs 106
and TIMPs expression patterns in the developing heart and results in the abnormal cardiac 107 growth pattern and cardiomyocyte proliferation with the aberrant content of fibrillar collagen 108 network in fetal and neonatal hearts. Charles River Laboratories (Portage, MI) and were randomly divided into two groups: 1) 115 normoxic control, and 2) hypoxic treatment of 10.5% oxygen from gestational day 15 to day 21, 116 as described previously (50) . Hearts were obtained from day 21 fetal and day 7 neonatal rats of 117 mixed sex. The sample size was 4 or 5 pups per group. For Western immunoblots, hearts were 118 flash frozen in liquid nitrogen and stored at -80°C until analysis. For the tissue slide preparation, 119 hearts were fixed in 10% buffered formalin and embedded in paraffin. All procedures and 120 protocols used in the present study were approved by the Institutional Animal Care and Use 121
Committee, and followed the guidelines by US National Institutes of Health Guide for the Care 122
and Use of Laboratory Animals. 123
Myocardial morphometry. Transverse sections of 5 μm prepared from the middle portion 124 of each heart were mounted and stained with hematoxylin and eosin. Sections were viewed at 125 20× or 40× magnification. The images were digitized and analyzed by the Image-Pro Plus image 126 analysis software. The left ventricular wall thickness was determined in the anterior wall (AW), 127 posterior wall (PW), septal wall (SW), and free wall (FW). 128
Collagen measurement. Fibrillar collagen structure and composition in fetal and neonatal 129 hearts were examined by scanning electron microscopy (SEM), as described previously (35) . 130
Briefly, the fetal and neonatal hearts were fixed in 2.5% glutaraldehyde and stored at 4°C until 131 processing. Hearts were immersed in 10% NaOH for 2-4 days at room temperature, and then 132 rinsed in distilled water for several times until the heart became transparent. Hearts were then 133 treated with 1% aqueous solution of tannic acid for 2-3 h, rinsed in distilled water for overnight, 134 and postfixed in 1% aqueous solution of OsO 4 for 1-2 h. The specimens were dehydrated in a 135 series of increasing ethanol concentrations (50, 80 , and 100%) and further dehydrated by critical 136 point drying at 31°C for 5-10 min. The samples were then mounted on a specimen holder for 137 drying overnight in a desiccator, coated with gold and examined with a Philips XL-20 SEM. 138
High-resolution digital images were acquired directly to a computer. The collagen deposition in 139 the heart was also determined by collagen staining using Picrosirius Red that binds specifically 140 to collagens. Paraffin sections were first dewaxed, then further deparaffinized by xylene and 141 rehydrated sequentially in ethanol. Rehydrated sections were hematoxylin stained and washed 142 for 10 min in water. The sections were stained in 0.1% picrosirius red for 1 h followed by 143 washing in two changes of acidified water (5 ml glacial acetic acid in 1 liter of water). Slides 144
were then dehydrated again in increasing concentrations of ethanol up to 100%, followed by 145 washing in xylene and mounted. Sections were viewed at 20 or 40× magnification, and the 146 images were digitized and analyzed by the Image-Pro Plus image analysis software. Soluble 147 collagen content was determined using the QuickZyme collagen assay kit (QuickZyme 148 Biosciences, Netherlands) according to the instructions of the manufacturer. Briefly, hearts were 149 homogenized in 0.5 M acetic acid and pepsin (1:10 weight/tissue wet weight) and incubated 150 overnight at 4 °C. The samples were then centrifuged (10 min at 14,000 rpm), the supernatant 151 was collected and total protein was quantified. Samples (200 µg) and the collagen standard were 152 added to assigned wells in a 96-well plate, and the dilution buffer was added to each well to a 153 final volume of 140 µL/well. The Sirius Red dye solution was added to each well, and the plate 154 was sealed and incubated on ice with gently shaking for 20 min. The plate was then centrifuged 155 at 3000 ×g at 4 °C. The collagen fiber that binds to Sirius Red dye forms a pellet at the bottom of 156 the well. The pellets were washed 3 times with the washing buffer. The detection buffer was 157 added to the pellets and mixed thoroughly and the signal was read at 540 nm. A standard curve 158 was generated using the collagen standard provided by the kit and collagen content (µg) per well 159 was determined. All steps were performed on ice to avoid degradation of the collagen fibers. 160
Ki-67 staining. The application of the nuclear protein, Ki-67, was used to determine the 161 cell proliferation of cardiomyocytes, as described previously (49). Hearts were fixed in 10% 162 neutral buffered formalin and embedded in paraffin. Immunohistochemical detection of 163 proliferation marker Ki-67 was performed using BD Pharmingen anti-Ig HRP detection kit. 164
Briefly, transverse slices of hearts were first deparaffinized in xylene and rehydrated with a 165 series of decreased concentrations of alcohol (100%, 95%, 90%, 75%). To block the endogenous 166 peroxidase activity, the slices were incubated with 0.3% H 2 O 2 for 10 min. Nonspecific binding 167 sites was blocked for 1 h at room temperature in a Tris-buffered saline solution containing 5% 168 bovine serum albumin. The slices were then incubated with mouse monoclonal antibody against 169
Ki-67 (1:50, Abcam Inc, Cambridge, MA) for overnight at 4 °C. The slices were rinsed three 170 times in phosphate-buffered saline for 5 min each time, followed by incubation with biotinylated 171 goat anti-mouse IgG (1:50, BD Pharmingen) for 60 min at room temperature. The samples were 172 then exposed to streptravidin-HRP and reacted with diaminobenzidine substrate solution 173 according to the manufacture's recommendations. The slices were viewed with a Zeiss 174 microscope, and images were captured with an attached SPOT digital camera imaging system. 175
Western blot analysis. Hearts were homogenized in a lysis buffer containing 150 mM 176 NaCl, 50 mM Tris.HCl, 10 mM EDTA, 0.1% Tween-20, 1% Triton, 0.1% β-mercaptoethanol, 177 0.1 mM phenylmethylsulfonyl fluoride (PMSF), 5 µg/ml leupeptin, and 5 µg/ml aprotinin, pH 178 7.4 and allowed to incubate for 1 h on ice. Homogenates were then centrifuged at 4 °C for 10 179 min at 10,000 ×g, and supernatants collected. Protein concentrations were measured using a 
Effect of hypoxia on fetal and neonatal heart weight and ventricular wall thickness. 212
Maternal hypoxia significantly decreased fetal (3.9 ± 0.1 g vs. 3.2 ± 0.1 g, p < 0.05) and neonatal 213 (15.0 ± 0.3 g vs. 9.2 ± 0.6 g, p < 0.05) body weight. There was no significant difference in fetal 214 heart weight between the control and hypoxic animals (23.9 ± 0.9 mg vs. 22.6 ± 0.7 mg, p > 215 0.05). However, hypoxia significantly increased the heart to body weight ratio in fetal rats (6.1 ± 216 0.1 mg/g vs. 7.0 ± 0.2 mg/g, p < 0.05). Neonatal heart weight was significantly decreased in 217 hypoxic animals (119.5 ± 3.6 mg vs. 75.8 ± 6.0 mg, p < 0.05), while the heart to body weight 218 ratio in neonatal rats was not changed by hypoxia (8.0 ± 0.2 mg/g vs. 8.2 ± 0.5 mg/g, p > 0.05). 219
To determine the effect of hypoxia on left ventricular wall thickness, hematoxylin and eosin-220 stained tissue slides were examined. As shown in Fig. 1 , the thickness of anterior wall, septal 221 wall and free wall was decreased in the fetal heart by hypoxia. As expected, the wall thickness of 222 left ventricle was significantly increased in the neonatal heart, as compared with that of fetal 223 heart. However, fetal hypoxia resulted in significant decreases in the thickness of anterior wall, 224 posterior wall, septal wall and free wall of left ventricle in the neonatal heart (Fig. 1) . 225
Additionally, the epicardial detachment from underling myocardium was seen in all samples of 226 fetal hearts treated with maternal hypoxia (Fig. 1) . 227
Effect of hypoxia on fibrillar collagen structure and composition in fetal and neonatal 228
hearts. Fibrillar collagen structure and composition were assessed by scanning electron 229 microscope in the heart from fetal and neonatal rats. As shown in Fig. 2 , fibrillar collagen fibers 230 were cross-linked randomly to form a complicated matrix network in both fetal and neonatal 231 hearts. Maternal hypoxia did not change collagen matrix in the fetal heart, but increased fibrillar 232 collagen weave matrix in the neonatal heart (Fig. 2) . The collagen content and distribution in the 233 left ventricle were examined further by the collagen staining using picrosirius red. As shown in 234 Fig. 3A , collagen forms the fiber bundles in the interstitial space. Maternal hypoxia did not 235 change the total collagen content in the fetal heart but increased it in the neonatal heart (Fig. 3A) . 236
The soluble collagen content in the heart was determined using a collagen assay kit. Fig. 3B  237 shows that maternal hypoxia had no significant effect on soluble collagen content in the fetal 238 heart. The collagen content in the heart showed a development-dependent increase from the fetus 239 to the neonate, and maternal hypoxia resulted in a significantly greater increase in fibrillar 240 collagens in the neonatal heart (Fig. 3B ). The expression of major types of collagens in the heart, 241 collagen I and collagen III, were determined by Western blots (Fig. 3C) . Maternal hypoxia 242 caused a reduction in collagen I in the fetal heart but a significant increase in collagen I in the 243 neonatal heart. In contrast, collagen III levels were not significantly altered in either fetal or 244 neonatal hearts. (Fig. 4) . Additionally, cardiomyocyte proliferation showed a development-252 dependent decrease from the fetal to the neonatal heart (Fig. 4) . MMP-1 expression was decreased in the fetal heart, but was increased in the neonatal heart. 259
Although it may be debating whether rodents express MMP-1, previous studies clearly 260 demonstrated the expression of MMP-1 in rat hearts (8, 25) . MMP-13 was increased in both the 261 fetal and neonatal hearts. MT1-MMP was increased only in the fetal heart. In contrast, the 262 expression of active MMP-2 and MMP-9 were not altered in either fetal or neonatal hearts. 263
Additionally, the proteolytic activities of MMP-2 & -9 were measured with gelatin zymography. 264
As shown in Fig. 6 , there was a lack of activity of active MMP-9 at 82 kDa in fetal or neonatal 265 hearts. MMP-2 activities at 62 kDa and 72 kDa were detected, but were not significantly altered 266 by maternal hypoxia in either fetal or neonatal hearts. Although maternal hypoxia had no 267 significant effect on TIMP-1 and TIMP-2 expressions, it significantly increased TIMP-3 and 268 TIMP-4 levels in both the fetal and neonatal hearts (Fig. 7) . Table 1 The present study demonstrates in a rat model that maternal chronic hypoxia causes 275 remodeling of the developing heart in the fetus and neonate by decreasing cardiomyocyte 276 proliferation and increasing the collagen deposition. Previous studies demonstrated that maternal 277 hypoxia increased hypoxia-inducible factor 1α (HIF-1α) protein levels in rodent fetal hearts (3, 278 39), indicating tissue hypoxia of the fetal heart in response to maternal hypoxia. In the present 279 study, the finding that maternal hypoxia significantly decreased immunostaining of the 280 proliferation marker Ki-67 in fetal and neonatal hearts is intriguing. Although Ki-67 is a 281 nonspecific cell proliferation marker and may stain both cardiomyocytes and cardiac fibroblasts, 282 the previous finding that hypoxia promoted cardiac fibroblast proliferation in rodents and 283 humans (1, 22) suggests that the maternal hypoxia-mediated decrease in the Ki-67 staining in 284 fetal and neonatal hearts in the present study is primarily due to the reduced cardiomyocyte 285 proliferation. In rat heart development, the transition of proliferative and hyperplasic growth of 286 mononucleated cells to hypertrophic growth of binucleated cells and terminal differentiation of 287 cardiomyocytes take place within the first two weeks after birth (30). Consistent with the present 288 finding, previous studies demonstrated an increase in the percentage and cell size of binuleated 289 myocytes in fetal rat heart in response to maternal hypoxia (3), an early morphologic indicator of 290 cardiomyocyte hypertrophy (9). Taken together, these studies suggest that fetal hypoxia causes a 291 premature exit of the cell cycle in the fetal heart leading to a fewer but larger cardiomyocytes in 292 offspring. Indeed, enlarged myocytes have been demonstrated in the heart of adult offspring rats 293 that had been exposed to hypoxia before birth (28, 47). The finding of maternal hypoxia-294 mediated remodeling of the heart during its critical developmental stages of the fetus and neonate 295 suggests programming of aberrant heart function. Indeed, the functional impact of remodeling on 296 postnatal development in the adult heart has been demonstrated in an essentially same animal 297 model of maternal hypoxia, in which reduced MMP-2 and enhanced collagen accumulation were 298 found along with left ventricular hypertrophy and stiffening, diastolic dysfunction, and increased 299 ischemic injury in 4 and 7 month old offspring (47). Similar findings that maternal hypoxia 300 causes fetal programming of ischemia-sensitive phenotype in the adult heart have been 301 demonstrated in our previous studies (28, 29, 37, 48, 50). 302
Whereas the mechanisms underlying the hypoxia-mediated reduction of myocyte 303 proliferation in the fetal heart remain elusive, the present finding of the epicardial detachment in 304 the hypoxic fetus provides a possible mechanism by which hypoxia inhibits proliferative and 305 hyperplasic growth of the fetal heart. During the fetal development, the epicardium provides 306 the precursor cells that give rise to various cell types in the heart, and it also supplies multiple 307 growth factors to stimulate cardiac myocyte proliferation, including fibroblast growth factor 308 (FGF)-2, Wingless-type MMTV integration site (Wnt)-9b, FGF-9 and other epicardially-derived 309 factors (34, 39). The detachment of epicardium from myocardium is likely to reduce the 310 availability of mitogenic factors and growth factors to the myocardium and subsequently 311 to inhibit myocardial proliferation (39). Additionally, the present study demonstrates that fetal 312 hypoxia increases TIMP-3 and TIMP-4 expression levels in both fetal and neonatal hearts, 313
suggesting another possible mechanism in the hypoxia-mediated down-regulation of myocyte 314 proliferation. In addition to their roles in modulating MMPs, it has been demonstrated that both 315 TIMP-3 and TIMP-4 play a key role in inhibiting cardiomyocyte proliferation in rat hearts 316 possibly in a MMP-independent and receptor-mediated manner (13, 16, 17, 42).
In the present study, the finding that maternal hypoxia causes an increased fibrillar 318 collagen content in neonatal, but not fetal, hearts is intriguing, and suggests a critical window in 319 compensatory remodeling of the collagen matrix in the neonatal heart resulting from hypoxia-320 mediated premature exit of cell cycle in the fetal heart. In the heart, collagens are the primary 321 extracellular proteins supporting the myocardium and determining the tissue stiffness. The 322 present study demonstrates that hypoxia differentially regulates collagen I and collagen III 323 expression in the developing heart. The increased collagen content found in the neonatal heart is 324 mainly due to an increase in collagen I. During the postnatal development, collagen I represents 325 more than 85% of the total collagen in the heart (7, 11). Unlike the finding in the neonatal heart, 326
collagen I was decreased in the fetal heart by hypoxia. Although it remains unclear what is the 327 major type of collagens in the fetal heart, collagen III is suggested to be one of the most 328 important fibrillar collagens in the heart during the fetal development (21). The finding that 329 hypoxia did not significantly affect collagen III levels in the fetal heart consists with the lack of 330 apparent changes in the total fibrillar collagen content in the fetal heart. Although the lack of 331 changes in collagen III was also demonstrated in neonatal hearts in the present study, a previous 332 study showed that maternal hypoxia increased the deposition of both collagen I and III in the 333 heart of adult offspring (47), suggesting a continuous remodeling process in the heart during the 334 postnatal development. 335
The present findings of decreased MMP-1 in the fetal heart and increased MMP-1 in the 336 neonatal heart are somewhat surprising, given that MMP-1 as collagenase 1 is a primary enzyme 337 that digests collagen I. This suggests a complex pattern of the interaction between collagens and 338 MMPs in the developing heart. It is possible that fetal hypoxia caused an imbalance of collagen 339 synthesis and degradation in the developing heart with the effect of synthesis predominant. is primarily expressed in fibroblasts that are the major source of ECM components and MMPs 354 (15, 24). Similarly, MMP-13 (collagenase 3) was significantly increased by hypoxia in both fetal 355 and neonatal hearts, whereas collagen III remained unchanged. This further supports the notion 356 that fibrillar collagens in the developing heart are regulated primarily through their synthesis 357 rather than their degradation via collagenases. In addition to collagenases, MT1-MMP is another 358 primary enzyme that digests fibrillar collagens in the heart (10, 36). The increased MT1-MMP 359 levels in the hypoxic fetal heart may contribute to the decreased collagen I, and the lack of MT1-360 MMP increment in the neonatal heart may enhance the accumulation of collagen I synthesis 361 resulting from fetal hypoxia. While collagenases (MMP-1 and MMP-13) possess high substrate 362 specificity for fibrillar collagens, MT1-MMP has been shown to degrade nonmatrix substrates 363 including cytokines, bioactive peptides, and growth factors in the myocardium (40). It is possible 364 that the elevated MT1-MMP also contributes to the reduced cardiomyocyte proliferation 365 observed in the hypoxic fetal heart. The lack of effect of fetal hypoxia on MMP-2 and MMP-9 366 expression levels and activities and their endogenous inhibitors TIMP-2 and TIMP-1 in the heart 367 indicates the minimal role of the gelatinases in hypoxia-mediated remodeling of fetal and 368 neonatal hearts. Nonetheless, the active MMP-2 levels were found decreased in the heart of adult 369 rats that had been exposed to hypoxia before birth (47), suggesting a continuous programming of 370
MMPs expression patterns in the heart during the postnatal development. 371
The present study provides new insights in the maternal hypoxia-mediated heart 372 remodeling during its critical developmental stages of the fetus and neonate, and suggests a role 373 of altered MMP-TIMP expressing patterns in the developing heart. Although it is difficult to 374 demonstrate a true cause-effect relation of MMPs-TIMPs and cardiac remodeling in living 375 animals particularly in a pregnant animal model at present due to the lack of selective inhibitors 376 and the difficulty of their use in a pregnant animal model, as well as the difficulty of transgenic 377 approach in a rat model, the present findings provide important physiological information and 378 basis for future more mechanistic investigations possibly using an approach of siRNA in cultured 379 organ/heart or cardiomyocytes. Given that hypoxia is one of the most important and clinically 380 relevant stresses to the fetus, and that large epidemiological studies indicate a link between in 381 utero adverse stimuli during gestation and an increased risk of heart disease in the adulthood, the 382 possibility that fetal hypoxia may result in programming of a heightened vulnerability of 383 remodeling and failing heart later in life provides a mechanistic understanding worthy of 384 investigation in humans. Indeed, it has been shown in rats that antenatal hypoxia enhances 385 collagen accumulation and left ventricular hypertrophy along with stiffening, diastolic 386 dysfunction, and the increased heart susceptibility to ischemia and reperfusion injury in adult 387 offspring (28, 29, 37, 47, 48, 50) . Hearts were isolated from 21-day fetal (E21) and postnatal day 7 (PD7) rats in the control and 546 hypoxic groups. Fibrillar collagen structure and composition were examined by scanning 547 electron microscope. Hypoxia increased the collagen matrix in PD7 but not E21 hearts. The 548 images were representatives of the heart samples from 4 control E21, 4 hypoxic E21, 5 control 549 PD7, and 6 hypoxic PD7 rats. 
